Cargando…
Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
In 2015, as part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Fung et al., 2015), that described how we intended to replicate selected experiments from the paper "Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia&q...
Autores principales: | Shan, Xiaochuan, Fung, Juan Jose, Kosaka, Alan, Danet-Desnoyers, Gwenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487217/ https://www.ncbi.nlm.nih.gov/pubmed/28653617 http://dx.doi.org/10.7554/eLife.25306 |
Ejemplares similares
-
Correction: Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
por: Shan, Xiaochuan, et al.
Publicado: (2018) -
Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia
por: Fung, Juan José, et al.
Publicado: (2015) -
Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2015) -
Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2018) -
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2017)